Medical science has made tremendous progress in determining the links between single genes and disease outcomes. My Next Health examines the complexities of how many genes work together in concert with internal and external factors called epigenetics. We are a B2B company focused on the key human gene variations powering cellular pathways that impact human health. Our novel insights into genotype-phenotype associations have the potential to radically improve precision in healthcare and clinical trials.
MNH Business Lines
- CLINICAL TRIALS
- INFECTIOUS DISEASE APPLICATION
- RISK ASSESSMENT FOR INSURANCE INDUSTRY
- EXECUTIVE HEALTHCARE CLINICS
The public version will be available at www.mynexthealth.com.
Overview
OUR VISION
To improve human health by accelerating the world’s transition to precision medicine.
OUR MISSION
To disrupt the healthcare and wellness sector by deploying genomics-based intellectual property to clinical trials and healthcare providers.
A Revolutionary Approach to Healthcare Through the New Paradigm of Actionable Genomics
Medical science has made tremendous progress in determining the links between single genes and disease outcomes. My Next Health examines the complexities of how many genes work together in concert with internal and external factors called epigenetics. We are a B2B company focused on the key human gene variations powering cellular pathways that impact human health. Our novel insights into genotype-phenotype associations have the potential to radically improve precision in healthcare and clinical trials.
MNH Business Lines
- CLINICAL TRIALS
- INFECTIOUS DISEASE APPLICATION
- RISK ASSESSMENT FOR INSURANCE INDUSTRY
- EXECUTIVE HEALTHCARE CLINICS
The public version will be available at www.mynexthealth.com.
Overview
OUR VISION
To improve human health by accelerating the world’s transition to precision medicine.
OUR MISSION
To disrupt the healthcare and wellness sector by deploying genomics-based intellectual property to clinical trials and healthcare providers.